Cargando…

Early liver function improvement following successful treatment of chronic hepatitis C in patients with decompensated cirrhosis: a real-life study

OBJECTIVES: Despite higher rates of sustained virologic response (SVR), important concerns remain when patients with decompensated cirrhosis due to hepatitis C virus (HCV) are treated with direct-acting antiviral agents (DAA). Questions include efficacy, safety, and the magnitude of liver function i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lourenço, Mariana Sandoval, Zitelli, Patricia Momoyo Y., Cunha-Silva, Marlone, Oliveira, Arthur Ivan N., de Lima, Roque Gabriel Rezende, Evandro de Oliveira, Souza, Oliveira, Claudia P., Sevá-Pereira, Tiago, Carrilho, Flair J., Pessoa, Mario G., Mazo, Daniel F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculdade de Medicina / USP 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579851/ https://www.ncbi.nlm.nih.gov/pubmed/34817045 http://dx.doi.org/10.6061/clinics/2021/e3186

Ejemplares similares

Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil
por: Lourenço, Mariana Sandoval, et al.
Publicado: (2022)

The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C
por: Oliveira, Arthur Ivan N., et al.
Publicado: (2021)

Hepatitis E virus infection increases the risk of diabetes and severity of liver disease in patients with chronic hepatitis C virus infection
por: Zitelli, Patricia Momoyo Yoshimura, et al.
Publicado: (2021)

Evaluation of the Hepatocellular Carcinoma Predictive Scores PAGE-B and mPAGE-B among Brazilian Patients with Chronic Hepatitis B Virus Infection
por: Ferreira da Silva, Ana Caroline, et al.
Publicado: (2022)

Accuracy of transient elastography-FibroScan(®), acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C
por: Ragazzo, Taisa Grotta, et al.
Publicado: (2017)

Multiple hepatic metastases of cardiac angiosarcoma
por: Cunha-Silva, Marlone, et al.
Publicado: (2018)

Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin
por: Barbosa, Mary Ellen Dias, et al.
Publicado: (2017)

Six-minute walk test predicts future decompensation in patients with compensated liver cirrhosis
por: Henrique, Diane Michela Nery, et al.
Publicado: (2022)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Lactose intolerance: diagnosis, genetic, and clinical factors
por: Mattar, Rejane, et al.
Publicado: (2012)

Elevated calprotectin levels are associated with mortality in patients with acute decompensation of liver cirrhosis
por: Matiollo, Camila, et al.
Publicado: (2022)

Retrospective analysis of hepatitis B virus chronic infection in 247 patients: clinical stages, response to treatment and poor prognostic factors
por: Cunha-Silva, Marlone, et al.
Publicado: (2017)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
por: Kikuchi, Luciana, et al.
Publicado: (2014)

Is hepatic venous pressure gradient assessment required before liver resection in patients with cirrhosis and hepatocellular carcinoma?
por: Silva, Mauricio F., et al.
Publicado: (2013)

Strong correlation by ultrasonography of hepatomegaly and the presence of co-infection in HIV/HCV cirrhotic patients
por: Vezozzo, Denise Cerqueira Paranaguá, et al.
Publicado: (2013)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis
por: Mazo, Daniel FC, et al.
Publicado: (2013)

Different degrees of malnutrition and immunological alterations according to the aetiology of cirrhosis: a prospective and sequential study
por: Caly, Wanda Regina, et al.
Publicado: (2003)

A Fast and Cost-Effective Method for Identifying a Polymorphism of Interleukin 28B Related to Hepatitis C
por: Ferreira, Camila da Silva, et al.
Publicado: (2013)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Prescribing Medications in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Deepak N.
Publicado: (2011)

Management of Coagulopathy in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Pooja D., et al.
Publicado: (2011)

Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
por: Nadelson, Jeffrey, et al.
Publicado: (2016)

Frequency of gallstones and mean BMI in decompensated cirrhosis
por: Rai, Ayesha Aslam, et al.
Publicado: (2018)

Clinical impact of microbiome in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2018)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Micronutrient Deficiencies in Patients with Decompensated Liver Cirrhosis
por: Llibre-Nieto, Gemma, et al.
Publicado: (2021)

Acute Myeloid Leukemia Masquerading as Decompensated Cirrhosis
por: Ahdi, Hardeep S, et al.
Publicado: (2022)

Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
por: Gurbuz, Berivan, et al.
Publicado: (2023)

Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?
por: Crocombe, Dominic, et al.
Publicado: (2023)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
por: Balcar, Lorenz, et al.
Publicado: (2022)

Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence
por: Da Fonseca, Leonardo G., et al.
Publicado: (2022)

Clinical spectrum and therapeutic approach to hepatocellular injury in patients with hyperthyroidism
por: de Campos Mazo, Daniel Ferraz, et al.
Publicado: (2013)

Buschke-Lowenstein tumor in a patient with decompensated cirrhosis
por: Shailesh, F. N. U., et al.
Publicado: (2014)

Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis
por: Rachakonda, Vikrant, et al.
Publicado: (2016)

Cryptococcemia in an HIV-negative patient with decompensated liver cirrhosis
por: Kandula, Manasa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_enjo6adttmvklhorsq2jbqj8tp